Sigyn Therapeutics, Inc.
SIGY
$2.76
-$0.99-26.40%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -117.05% | -27.89% | 56.32% | -38.79% | -13.76% |
| Total Depreciation and Amortization | -100.00% | 0.00% | 0.00% | 0.00% | -6.67% |
| Total Amortization of Deferred Charges | 0.90% | 12.95% | -70.20% | 40.08% | 104.58% |
| Total Other Non-Cash Items | 1,715.20% | 290.84% | -108.96% | 680.00% | 0.00% |
| Change in Net Operating Assets | 33.53% | 34.34% | -60.31% | -1.39% | 6.98% |
| Cash from Operations | 48.23% | -1.45% | -77.17% | 10.39% | 22.41% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -52.57% | 63.09% | -39.97% | 31.89% | -17.41% |
| Total Debt Repaid | -- | -- | -63.16% | -6.40% | -25.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -52.57% | 114.53% | -49.96% | 35.07% | -20.72% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,650.00% | 100.52% | -237.35% | 434.13% | -1.42% |